E-Pub Full Text Articles

Brevifoliol and its Analogs: A New Class of Antitubercular Agents

Author(s): Balakishan Bhukya*, Sarfaraz Alam, Vinita Chaturvedi, Priyanka Trivedi, Shailesh Kumar, Feroz Khan, Arvind S. Negi and Santosh Kumar Srivastava
Pages: 1-19 (19)
Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors

Author(s): Pankaj Wadhwa, Priti Jain and Hemant R Jadhav*
Pages: 1-13 (13)
Computer-Aided Structure Prediction of Bluetongue Virus Coat Protein VP2 Assisted by Optimized Potential for Liquid Simulations (OPLS)

Author(s): Leena Prajapati, Ravina Khandelwal, Kadapakkam Nandabalan Yogalakshmi, Anjana Munshi* and Anuraj Nayarisseri*
Pages: 1-13 (13)
Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer

Author(s): Bharat Goel, Nancy Tripathi, Nivedita Bhardwaj and Shreyans K Jain*
Pages: 1-29 (29)
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery

Author(s): Ariane Sternberg, Dwight L. McKee and Cord Naujokat*
Pages: 1-11 (11)
On the Possible Relevance of Bottom-Up Pathways in the Pathogenesis of Alzheimer’s Disease

Author(s): Friedrich Leblhuber*, Kostja Steiner, Simon Geisler, Dietmar Fuchs and Johanna M. Gostner
Pages: 1-7 (7)
The Evolution of Computational Chemistry Along with Coronaviruses

Author(s): Weng Ieong Tou*, Kuok Wa Tam and Hou Ng
Pages: 1-3 (3)
Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics

Author(s): Norikazu Kiguchi*, Huiping Ding, Shiroh Kishioka and Mei-Chuan Ko
Pages: 1-11 (11)
COVID-19: An Update on Clinical Trials

Author(s): Yogesh Kumar, Anil Kumar Singh and Shiv Kumar
Pages: 1-2 (2)
COVID-19 Pandemic – Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis?

Author(s): Yogesh Kumar and Akanksha Jain
Pages: 1-2 (2)
Research Progress in Flavonoid Anticancer Drugs Including Synergy with Other Approaches

Author(s): Yusuf Hussain, Suaib Luqman and Abha Meena*
Pages: 1-19 (19)
Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future Prospects

Author(s): Prashant S. Kharkar*
Pages: 1-13 (13)
Aiming at Ideal Therapeutics-MOPr/DOPr or MOPr-DOPr Heteromertargeting Ligand

Author(s): Wakako Fujita*
Pages: 1-9 (9)
Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement

Author(s): Darby J.E. Lowe, Daniel J. Müller* and Tony P. George
Pages: 1-17 (17)
Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions

Author(s): Esra Küpeli Akkol*, Fatma Tuğçe Gürağaç Dereli, Eduardo Sobarzo-Sánchez and Haroon Khan
Pages: 1-19 (19)
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time

Author(s): Amit Kumar Banerjee* and Neelima Arora*
Pages: 1-4 (4)
δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects

Author(s): Shigeto Hirayama and Hideaki Fujii*
Pages: 1-14 (14)
The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds

Author(s): Hua Guo* and Quan-Ping Diao
Pages: 1-5 (5)
Recent Advances in β-lactam Derivatives as Potential Anticancer Agents

Author(s): Xinfen Zhang and Yanshu Jia*
Pages: 1-13 (13)
1,3,5-Triazine-azole Hybrids and their Anticancer Activity

Author(s): Hua Guo* and Quan-Ping Diao
Pages: 1-12 (12)
The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids

Author(s): Ya-Zhou Zhang, Hai-Lin Liu, Qian-Song He and Zhi Xu*
Pages: 1-6 (6)
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward

Author(s): Danny Feijtel, Marion de Jong and Julie Nonnekens*
Pages: 1-11 (11)
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents

Author(s): Xiaoyue Wen, Yongqin Zhou*, Junhao Zeng and Xinyue Liu
Pages: 1-20 (20)
Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities

Author(s): Mingli Yang, Hailin Liu*, Yazhou Zhang*, Xiujun Wang* and Zhi Xu
Pages: 1-6 (6)
Periodontal Pathogens and Neuropsychiatric Health

Author(s): Abhishek Wadhawan, Mark A. Reynolds, Hina Makkar, Alison J. Scott, Eileen Potocki, Andrew J. Hoisington, Lisa A. Brenner, Aline Dagdag, Christopher A. Lowry, Yogesh Dwivedi and Teodor T. Postolache*
Pages: 1-45 (45)
Withdrawal Notice: Updated Understanding of the Degenerative Disc Diseases - Causes Versus Effects - Treatments, Studies and Hypothesis

Author(s): Cristian Muresanu, Siva G. Somasundaram, Margarita E. Neganova, Elena V. Bovina, Sergey V. Vissarionov, Okom N. F. C. Ofodile, Vladimir P. Fisenko, Valentin Bragin, Nina N. Minyaeva, Vladimir N. Chubarev, Sergey G. Klochkov, Vadim V. Tarasov, Cecil E. Kirkland and Gjumrakch Aliev*
Pages: 1-1 (1)
Withdrawal Notice: A Chlorhexidine-containing Brush-on Gel as Adjuvant Treatment for Plaque-Induced Gingivitis

Author(s): Gianna Maria Nardi , Roberta Grassi, Guglielmo Campus, Maria Letizia Pareti , Dario Di Stasio and Fedora della Vella*
Pages: 1-1 (1)
Withdrawal Notice: The Long-Term Effect of Medically Enhancing Melanin Intrinsic Bioenergetics Capacity in Prematurity

Author(s): Arturo Solís Herrera, Paola E. Solís Arias, María del Carmen Arias Esparza, Luis Fernando Torres Bernal, Andrey D. Bondarev, Vladimir P. Fisenko, Vladimir N. Chubarev, Nina N. Minyaeva, Lyudmila M. Mikhaleva, Vadim V. Tarasov, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*
Pages: 1-1 (1)
Withdrawal Notice: The Association of Sleep Disorders, Obesity, and Sleep-Related Hypoxia with Cancer

Author(s): Anna Brzecka, Karolina Sarul, Tomasz Dyła, Marco Avila-Rodriguez, Ricardo Cabezas-Perez, Vladimir N. Chubarev, Nina N. Minyaeva, Sergey G. Klochkov, Margarita E. Neganova, Liudmila M. Mikhaleva, Siva G. Somasundaram, Cecil E. Kirkland, Vadim V. Tarasov and Gjumrakch Aliev*
Pages: 1-1 (1)
Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder

Author(s): Alexander Maget, Martina Platzer*, Susanne A. Bengesser, Frederike T. Fellendorf, Armin Birner, Robert Queissner, Carlo Hamm, Bernd Reininghaus, Andrzej Hecker, Lukas Tomberger, Renè Pilz, Nina Dalkner, Natalie Moll, Gregor Schütze, Markus Schwarz, Hans P. Kapfhammer and Eva Z. Reininghaus
Pages: 1-9 (9)

E-Pub Full Text Articles

Brevifoliol and its Analogs: A New Class of Antitubercular Agents

Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors

Computer-Aided Structure Prediction of Bluetongue Virus Coat Protein VP2 Assisted by Optimized Potential for Liquid Simulations (OPLS)

Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer

Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery

On the Possible Relevance of Bottom-Up Pathways in the Pathogenesis of Alzheimer’s Disease

The Evolution of Computational Chemistry Along with Coronaviruses

Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics

COVID-19: An Update on Clinical Trials

COVID-19 Pandemic – Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis?

Research Progress in Flavonoid Anticancer Drugs Including Synergy with Other Approaches

Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future Prospects

Aiming at Ideal Therapeutics-MOPr/DOPr or MOPr-DOPr Heteromertargeting Ligand

Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement

Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions

Coronavirus Disease (COVID-19) Pandemic: A Race Against Time

δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects

The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds

Recent Advances in β-lactam Derivatives as Potential Anticancer Agents

1,3,5-Triazine-azole Hybrids and their Anticancer Activity

The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids

Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward

Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents

Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities

Periodontal Pathogens and Neuropsychiatric Health

Withdrawal Notice: Updated Understanding of the Degenerative Disc Diseases - Causes Versus Effects - Treatments, Studies and Hypothesis

Withdrawal Notice: A Chlorhexidine-containing Brush-on Gel as Adjuvant Treatment for Plaque-Induced Gingivitis

Withdrawal Notice: The Long-Term Effect of Medically Enhancing Melanin Intrinsic Bioenergetics Capacity in Prematurity

Withdrawal Notice: The Association of Sleep Disorders, Obesity, and Sleep-Related Hypoxia with Cancer

Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder